Posted On: 03/01/2016 9:52:04 AM
Post# of 72444

Sorry but I don't believe this for 1 second.
"As the trial is a randomized, double-blind design with a placebo arm, we, nor anyone, can speculate on the outcome until all data is collected, un-blinded and analyzed." commented Leo Ehrlich, Chief Executive Officer at Cellceutix
The patients either still have psoriasis or they don't...P works or it doesn't..
"As the trial is a randomized, double-blind design with a placebo arm, we, nor anyone, can speculate on the outcome until all data is collected, un-blinded and analyzed." commented Leo Ehrlich, Chief Executive Officer at Cellceutix
The patients either still have psoriasis or they don't...P works or it doesn't..


Scroll down for more posts ▼